Clinical trials
Neurologic Manifestations trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 5 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| University Hospital, Toulouse | 2 |
| 5 Santé | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Centre Hospitalier de Saint-Denis | 1 |
| Eli Lilly and Company | 1 |
| Fondation Ophtalmologique Adolphe de Rothschild | 1 |
| Friedreich's Ataxia Research Alliance | 1 |
| Institut Curie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurologic Manifestations | 23 |
| COVID-19 | 5 |
| Nervous System Diseases | 4 |
| Blindness | 2 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Eye Abnormalities | 2 |
| Eye Diseases | 2 |
| Eye Diseases, Hereditary | 2 |
| Heart Arrest | 2 |
Trials
Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.